Biogen Inc. raised its full-year financial guidance as growing sales of its Alzheimer’s drug helped the biotech company beat ...

In a 51–47 vote along party lines, the Senate confirmed Monarez as the director of the Centers for Disease Control and ...

Among 24 such systems (called devices in FDA parlance) authorized since 2015, FDA summaries for 14 lacked data on the ...

A new technology that harnesses artificial intelligence (AI) to analyze mammograms and improve the accuracy of predicting a ...

Swadeshi Jagran Manch urges CDSCO for clarity in biosimilar guidelines to ensure high-quality, cost-effective production in India.

DIRECTING A CHANGING CDC — The Senate voted to confirm Susan Monarez as the next CDC director Tuesday, marking an end to the ...

These guidelines help ensure that products are fit for their intended use and comply with applicable regulatory standards.

Gain insights from TransMedics Group’s Q2 2025 earnings, highlighting 38% YoY revenue growth, raised full-year guidance, and innovation-driven future growth.

Ionis Pharmaceuticals Q2 2025 earnings highlight strong Tryngolza sales, increased 2025 revenue guidance, and upcoming Donidalorsen FDA approval.

GSK tops Q2 estimates with growth in vaccines and specialty drugs, raises 2025 forecast amid progress in major late-stage ...

Leveraging the power of Microsoft Cloud for health authority queries to create streamlined, efficient processes.